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This paper identifies issues associated with field disease data and their implications on the
interpretation of estimated genetic parameters and experimental designs. The main focus
is on concepts relating to the impacts of diagnostic test properties and exposure to infec-
tion, and how exposure to infection is intricately related to within-herd epidemic dynamics.
The following are raised challenges: (i) to more fully understand and describe the dynamic
impacts of disease epidemics on genetic interpretations; (ii) to develop statistical methods
to jointly estimate epidemiological and genetic parameters from complex epidemiological
data; (iii) to develop and explore optimal experimental designs for case-control studies,
exploiting field disease data. Solving these problems would add insight to both disease
genetic and epidemiological studies, as well as enabling us to better select animals for
increased disease resistance.
Keywords: epidemiology, animal, heritability, genome wide association analysis, field data
INTRODUCTION
High throughput genomics techniques open hitherto unforeseen
opportunities for dissecting, and genetically improving, complex
traits in livestock. Foremost amongst complex traits is resistance
to infectious disease, which is now the focus of many studies. A
detailed appraisal of infectious diseases that may be amenable to
host genetic studies is presented by Davies et al. (2009). Disease
genetics studies typically require observations on many animals
in order to quantify genetic variation or perform a genome scan
of sufficient power. This usually necessitates utilizing field data
because, with the exception of some aquacultural species (e.g.,
Moen et al., 2009; Houston et al., 2010), challenge experiments
of a sufficient scale are not possible. For example, data may be
captured from populations suffering endemic diseases with pre-
dictable prevalence, or from a population undergoing an epidemic
such as bovine tuberculosis (Brotherstone et al., 2010) or infec-
tious pancreatic necrosis (IPN; Houston et al., 2008). However
this requirement for extensive data can also be turned into an
opportunity, as dense SNP-chip based genomic prediction tech-
niques provide the means to retrieve genetic information where
it would otherwise not have been possible. Consider a population
undergoing an epidemic; even in the absence of known pedigrees
or reliable animal identification, classification of DNA as coming
from cases or control may enable the development of genomic
predictors of resistance that can (in principle) be applied to any
animal from the same breed.
Before using field disease data for any genetic study, its prop-
erties must be understood. A generic problem with field disease
data is that it is very “noisy”: diagnosis of infection or disease
may be imprecise, it can be difficult to determine when infec-
tion of an individual occurred and it is often unclear whether
or not apparently healthy individuals have been exposed to the
infection. These factors can greatly complicate the interpreta-
tion of field disease data and even lead to skepticism by some
regarding its usefulness at all. However, from an analytical per-
spective, they are merely biases that in principle can be fac-
tored into any expectation or analysis. These concepts, and the
impacts of these “noise” factors on variance component esti-
mation, were first presented by Bishop and Woolliams (2010).
These authors derived formulae, in the context of viral or bac-
terial infections, to illustrate the biases to estimated heritabil-
ities caused by incomplete exposure or imperfect diagnosis of
infection.
Here we further develop the necessary concepts to interpret
field disease data and summarize their impact on heritability and
SNP association studies. Additionally, we consider how the inter-
pretation of SNP association studies may be influenced by the data
collection strategies, we suggest experimental designs for genome
scans which may perform better than classic matched case-control
studies and we identify issues yet to be resolved.
DISEASE DATA PROPERTIES: ASSUMING STATIC
CONDITIONS
In reality most field disease data is collected from a dynamic epi-
demic situation, where the number of infected animals changes
over time, due to interactions between infected and susceptible
individuals. These are complex functions of environmental and
host genetic factors. Analogies may be drawn between the spread
of infection and so-called associative effects models (Muir, 1996;
Bijma et al., 2007) in which an animal’s phenotype is a func-
tion of its own phenotype and the phenotype of its herd mates.
For simplicity we firstly ignore such dynamic interactions, and
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consider the case of binary classification of animal phenotypes at
a particular point in time as healthy or diseased.
INCOMPLETE EXPOSURE TO INFECTION
Suppose there is an infective dose of pathogen (µ) which may
be expected to result in a typical animal becoming infected and
then diseased (i.e., showing clinical signs). Animals receiving an
infective dose greater than µ are defined as exposed, with the pro-
portion of animals in this category being ε. The fraction of the
whole population that is identified as diseased is a function of
(i) the proportion of individuals that have been exposed to the
pathogen (ε) and (ii) the virtual prevalence (p), i.e., the prevalence
when ε= 1. Assuming that exposure is random and independent
of host genotype, then the observed prevalence is εp. Of the 1− εp
proportion of individuals that are healthy,ε(1− p) are exposed and
apparently resistant, whilst (1− ε) have not yet been exposed and
have not expressed any genotype related to “disease resistance.”
The phenotypic variance of observed “disease resistance” is εp
(1− εp). Incomplete exposure results in a downwards bias in both
estimated SNP effects from association studies and heritabilities
as follows.
SNP effect biases
The bias in the estimated allelic substitution effect (α) is simply
the regression of observed phenotype on virtual phenotype (that
which would have been observed with complete exposure), i.e., ε.
Heritability biases
The heritability bias is a function of both the level of expo-
sure and, assuming an underlying normal distribution for lia-
bility, the altered prevalence thresholds. From Bishop and Wool-
liams (2010), heritabilities on the observed and liability scales
are ε2φ(xp)2(εp)−1(1− εp)−1h2 and ε2φ(xp)2φ(xεp)−2h2, respec-
tively, where h2 is the liability heritability with complete exposure
and φ(xp) is the corresponding normal density function evaluated
at xp.
IMPERFECT DIAGNOSTIC TESTS
Animals will be classified into healthy and diseased categories by
means of a diagnostic test. Implicit to all diagnostic tests are
the concepts of specificity and sensitivity. Specificity (Sp) is the
probability that a truly healthy individual is classified by the diag-
nostic test as healthy and sensitivity (Se) is the probability that
a truly diseased individual is classified by the diagnostic test as
diseased. From Table 1 it can be seen that observed prevalence
(p′) can be expressed as a regression on true prevalence, i.e.,
p′= (1− Sp)+ (Sp+ Se− 1)p. Biases in estimated SNP effects
and heritabilities are as follows.
SNP effect biases
The bias in α is the regression of observed phenotype on true
phenotype, i.e. (Sp+ Se− 1).
Heritability biases
The heritability biases take the same form as for exposure, being a
function of the regression of observed on true and the altered lia-
bility thresholds. Thus, the heritabilities on the observed and liabil-
ity scales are, respectively (Sp+ Se− 1)2φ(xp)2p′−1(1− p′)−1h2
and (Sp+ Se− 1)2φ(xp)2φ(xp′)−2h2.
Table 1 | Proportions of individuals classified as healthy or diseased,
as a function of specificity (Sp) or sensitivity (Se).
Classification by diagnostic test Total
Healthy Diseased
True state Healthy (1−p)Sp (1−p)(1−Sp) 1−p
Diseased p(1−Se) pSe p
Total 1−p′=Sp−p
(Sp+Se−1)
p′= (1−Sp)
+p(Sp+Se−1)
COMBINING INCOMPLETE EXPOSURE AND IMPERFECT DIAGNOSES
Thus far, diagnostic test properties and exposure are consid-
ered independently, however often both factors will jointly affect
the observed data. It is readily shown from Table 1 that with
incomplete exposure and imperfect diagnostic tests, the observed
prevalence is p′= (1− Sp)+ (Sp+ Se− 1)εp, where p is the true
prevalence when ε= 1. It then follows that the bias in estimated
α is (Sp+ Se− 1)ε and the heritabilities on the observed and
liability scales are ε2(Sp+ Se− 1)2φ(xp)2p′−1(1− p′)−1h2 and
ε2(Sp+ Se− 1)2φ(xp)2φ(xp′)−2h2, respectively.
IMPLICATIONS OF VARIABLE INFECTION PRESSURE
In different disease or epidemic scenarios there will be differ-
ent infection pressures (B), i.e., dosage levels faced by animals
when challenged. This will cause ε to change as the propor-
tion of animals receiving an infective dose greater than µ will
vary as some function of B. This will lead to different estimated
SNP effects and heritabilities, as described above, however differ-
ences in B (and hence ε) will potentially also alter the apparent
mode of inheritance of the SNP effects (i.e., additive, recessive,
dominant).
For any given B value, and hence expected challenge level of
pathogen, an animal’s susceptibility to infection determines its
probability of becoming infected (hence diseased). For very low
challenges the probability of infection will be negligible, whereas
for very high challenges, an animal will become infected (provided
that it is genetically capable of being infected). This is analogous
to dosage levels in deliberate challenge studies where the dosage
may be calibrated to obtain a pre-determined mortality (e.g., 50%)
during the course of the trial.
The change in probability of infection as B increases may be
described by a dose-response curve. For illustration, assuming
that the probability of infection tends to κ as B becomes very
high this curve may be conveniently described by the cumulative
Normal distribution function ∫B0 κφ(x ;µ, σ2)dx , where µ is the
dosage level leading to a mean infection proportion of 0.5κ and
the σ determines the rate at which infection probability increases
as dosage increases.
Within a population, different genotypes may differ inµ and/or
σ. Similarly, the force of infection varies both between epidemics
and over time within an epidemic, leading to exposure probabili-
ties varying similarly. Dose-response curves for three hypothetical
genotypes differing in µ (homozygous susceptible, homozygous
resistant, and heterozygous) are plotted in Figure 1 (κ= 1). Whilst
the resistance allele will be declared additive for a wide range of
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FIGURE 1 | Infection probability as a function of dosage level for three
hypothetical major-gene genotypes, illustrating how the inferred mode
of resistance will change as dosage level changes.
B levels, at low levels it will be declared dominant whereas at
high B levels it will be thought to be partially recessive. Empirical
agreement comes from published results for resistance to the viral
disease IPN in Atlantic salmon, where a single QTL has been shown
in repeated studies to account for nearly all the genetic variation in
the resistance of salmon fry (Moen et al., 2009; Gheyas et al., 2010;
Houston et al., 2010). In the studies of Moen et al. and Gheyas
et al. where in the challenge tests the population average mortality
was close to 60 and 70%, respectively, the QTL effect was additive
with no evidence of dominance. However, in the study of Hous-
ton et al. population average mortality was 9%, and the resistance
haplotype was almost completely dominant over the susceptibility
haplotype.
DISEASE DATA PROPERTIES: ASSUMING DYNAMIC
CONDITIONS
The key factor ignored so far is that most epidemics are
dynamic ever-changing processes, with infectious animals infect-
ing immunologically susceptible animals. Thus an individual ani-
mal’s expressed phenotype is influenced by the phenotypes of
other animals in contact with it, a situation analogous to associa-
tive effects models (Muir, 1996; Bijma et al., 2007). The basic the-
oretical principles underlying epidemic processes have been well
and exhaustively described (Anderson and May, 1991), although
most theory assumes individuals are genetically homogeneous.
In terms of infection dynamics during an epidemic, the crit-
ical concept to note is that the infection pressure (i.e., B) will
change as the number of infectious animals changes. There-
fore, depending on when during an epidemic data is collected,
B and εwill change, and consequently inferences made about SNP
effects, SNP inheritance patterns and heritabilities will all alter.
However, these changes are complex and will depend upon the
transmission properties of the infection. Simple principles are now
described.
Consider a simple situation in which animals are defined as
being in one of three categories, viz. (i; immunologically) suscep-
tible to infection, (ii) infected and infectious, or (iii) recovered
from infection (and consequently no longer infectious or suscep-
tible to infection). The numbers of animals in each category at any
FIGURE 2 | Numbers of infectious animals during the course of an
hypothetical epidemic, for three modes of transmission of infection, (i)
SI model in which infected animals remain infectious, (ii) SIR model in
which infected animals recover so that they are no longer infectious
and remain immune to the infection, (iii) SIRS model in which
recovered animals lose their immunity and become immunologically
susceptible again. Non-zero parameter values are identical for each model.
Population size is 1000 animals.
point in time are S, I, and R, respectively. The epidemic dynamics
are: dS/dt =−βSI +λR, dI /dt = γI, and dI /dt = γI −λR, where
t is time (days), β is the transmission coefficient, γ is the rate of
recovery of infectious animals, and λ is the rate at which recovered
animals lose immunity and become immunologically susceptible
again. In an SI model, in which animals remain infectious after
becoming infected, γ and λ are both zero. In an SIR model recov-
ered animals do not lose immunity, hence λ is zero. In an SIRS
model, in which animals may potentially become infected mul-
tiple times, all three parameters are non-zero and an endemic
equilibrium prevalence may be reached.
Figure 2 presents a plot of the predicted number of infectious
animals for each model, for constant (arbitrary) non-zero para-
meters and a population size of 1000. The infection pressure B
will vary in proportion to βI, and this changes dramatically over
time and it varies markedly with transmission model. In an SI
model, B rises until all animals that can be infected have been
infected; in an SIR model B rises to a maximum and then declines
as most infectious animals recover; in an SIRS model (depending
on parameter combinations) B may rise then reach an equilib-
rium value. In the SIR model example shown, unexposed animals
remain in the population even after 350 days. In all three models,
the change in B with time indicates that there is genetic informa-
tion in when animals became infected, as well as which animals
became infected. In cases where animals are genetically hetero-
geneous, animals infected early in an epidemic became infected
when B was lower and therefore, chance contact effects aside, these
animals are more susceptible.
Fully accounting for the impacts of the dynamic nature of data
from disease epidemics remains a complex and unsolved problem.
Conclusions drawn will depend upon when during the epidemic
the data is recorded, the duration of data recording and the power
(i.e., sensitivity and specificity) of the diagnostic tests. For example,
a diagnostic test or data recording strategy which can determine
which animals have ever been infected or diseased will be more
powerful than one which can only detect currently infected or
diseased animals.
www.frontiersin.org June 2012 | Volume 3 | Article 114 | 3
Bishop et al. Interpreting disease resistance data
PERSPECTIVES
SYNOPSIS
Field data from infectious disease epidemics are interesting, infor-
mative, and complex. We have demonstrated that noise elements
associated with such data do cause biases in the results obtained,
however these biases can be predicted given knowledge of the
disease. Downward biases in estimated SNP effects are linear
with exposure probability or with diagnostic test inaccuracy,
whereas biases in heritabilities are more complex, being a func-
tion of altered disease prevalence and squared terms in exposure
or diagnostic test accuracy. Further, the apparent SNP mode of
inheritance may change with infection pressure and exposure
probability.
Interpretations of genetic parameters (i.e., variance compo-
nents and SNP effects) obtained from field data may change
substantially given knowledge of the disease biology. For exam-
ple, a genetic signal in field disease data, even a weak signal, may
well be indicative of much stronger underlying genetic control
of resistance or strong genetic control of the components of the
immune response that contribute to variation in disease resistance.
Specific examples where this may be the case (viz. the impact of
exposure on the heritability of IPN resistance in salmon and the
impact of imperfect diagnostic tests on the heritability of bovine
tuberculosis resistance) were elaborated by Bishop and Woolliams
(2010).
IMPLICATIONS FOR EXPERIMENTAL DESIGN
The results and principles discussed here may have implications
for optimal experimental design of case-control genome scans.
Consider the definitions of the cases and controls. Under the
assumption that the specificity of the diagnostic test is good
(i.e., very few false positives), then cases are self-evidently genet-
ically susceptible individuals that have been exposed to infection
and have been diagnosed as diseased. At best, controls have been
exposed to infection, have had the opportunity to express their
resistance genotype and have subsequently been correctly diag-
nosed as healthy. At worst, the controls have not been exposed
to infection or they have been misdiagnosed. In this worst case
scenario, controls will simply be representative of the population
average and (depending on the virtual prevalence) information
is still obtainable from the comparison of cases and population
average. This is the so-called “Wellcome Trust design”; although
the comparison of cases vs. average is less powerful than cases
vs. true controls, this weaker contrast may be offset in some cir-
cumstances by having a larger number of population average
animals available and genotyped. For example, this is the situ-
ation in dairy cattle breeding where large numbers of animals,
including all widely used sires, have been genotyped with SNP
chips.
Notwithstanding the appropriateness of the “Wellcome Trust
design” in some circumstances, improved designs for case-control
studies may be proposed from the results presented here. In most
situations, animals will be sampled across several herds, which will
differ in stage of epidemic and disease prevalence, so (assuming
that we target animals of the same breed and equivalent environ-
mental circumstances) the question is from which cohorts should
the animals be sampled, and when during an epidemic should this
sampling take place? Commonly used experimental protocols have
cases and controls matched for risk factors such as age, farm, and
sex. Whilst this may be an efficient design for investigating and
quantifying risk factors that are not a part of the objectives of the
experiment, it is potentially inefficient for identification of genetic
effects as it ignores genetic information that can be inferred from
epidemic dynamics. In other words, it is designed for the wrong
purpose. In general terms, controls sampled when prevalence, and
hence B, is low will be poorly informative and resemble popula-
tion average animals. Conversely, cases sampled when prevalence
is low (prior to peak prevalence) are likely to be those that are most
susceptible to infection whilst those sampled at peak prevalence
will contain animals that are amongst the least susceptible of the
ultimately infected animals.
We propose a more rational design for a case-control genome
scan study, such that epidemiological principles are incorporated
into the choice of cases and controls. In broad terms, the aim
is to target animals such that (i) cases are likely to be the most
susceptible, i.e., ideally they should be sampled from situations
where B and hence ε are low and (ii) controls have had max-
imal opportunity to demonstrate that they are truly resistant,
i.e., ideally they should be sampled from situations where B and
hence ε are high. Achieving this could utilize information both
within and across herds. Within a herd, all other factors being
constant, targeting earlier-infected animals as cases is likely to
increase their genetic differentiation from the population aver-
age, whilst controls should be those that remain uninfected even
at peak prevalence. In principle, similar information is obtain-
able from between-herd differences in prevalence, although there
are risks of hidden biases affecting outcomes – the most obvious
being herd-specific diagnostic test sensitivities. Targeted, rather
than random, sampling of animals from herds risks introducing
biases into the estimation of non-genetic effects, a situation also
true with conventional case-control designs. This may be partly
addressed by including some function of herd-level prevalence as
a covariate in analyses which combine data across herds. In all
situations, hidden genetic structure remaining in the data must be
corrected for using the genetic similarity information inherent in
SNP array (or sequencing) genotypes.
CHALLENGES
Understanding how disease and epidemiological factors affect dis-
ease data can greatly influence how we interpret the results, and
possibly even lead to more efficient experimental design. However,
the theory describing these impacts is still somewhat rudimentary
and concepts that have been presented have yet to be fully explored.
We see the following as challenges:
• To more fully understand and describe the dynamic impacts of
disease epidemics on genetic interpretations. We need to better
understand how type of epidemic, and sampling strategy dur-
ing the epidemic, influence estimated parameters and accuracy
of selection.
• To develop statistical methods to jointly estimate epidemiologi-
cal parameters (e.g.,β,γ) or concepts (e.g., exposure, sensitivity,
specificity) simultaneously with genetic parameters (e.g., her-
itability) from complex epidemiological data. Such methods
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will conceivably build on Bayesian frameworks which exist to
analyze epidemic data from heterogeneous populations.
• To further develop and explore optimal experimental designs
for case-control studies exploiting field disease data, and quan-
tify the consequences of GWAS studies performed in different
stages and different types of epidemics.
Meeting these challenges would formally bring together the dis-
ciplines of genetics and epidemiology, add considerable value to
ongoing disease genetic studies, allow us to better understand and
dissect host responses to infection, and enable us to better select
animals for improved resistance.
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